Close
FINDING CURES TOGETHER<sup>SM</sup>

AACR Annual Meeting 2019

Integrative Cancer Science • Global Impact • Individualized Patient Care 

Friday, March 29-Wednesday, April 3, 2019
Georgia World Congress Center

Atlanta, Georgia

Program Committee Chair
John D. Carpten, USC Keck School of Medicine, Los Angeles, California

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.  More information about the AACR Annual Meeting 2019 will be available online and in the Call for Abstracts in late August 2018. 

Program Committee Vice Chairs
Kenneth C. Anderson, Dana-Farber Cancer Institute, Boston, Massachusetts
Marcia R. Cruz-Correa, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
Todd R. Golub, Broad Institute of MIT and Harvard, Cambridge, Massachusetts
Stephen D. Hursting, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Patricia M. LoRusso, Yale Cancer Center, New Haven, Connecticut
Richard M. Marais, Cancer Research UK Manchester Institute, Manchester, United Kingdom
Aviv Regev, Massachusetts Institute of Technology and Broad Institute of MIT and Harvard, Cambridge, Massachusetts
Antoni Ribas, UCLA Medical Center, Los Angeles, California
Brian M. Rivers, Morehouse School of Medicine, Atlanta, Georgia
David A. Tuveson, Cold Spring Harbor Laboratory Cancer Center, Cold Spring Harbor, New York

Program Committee Cochairs
Nilofer S. Azad, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
Anna D. Barker, Arizona State University, Scottsdale, Arizona
Julian Blagg, Institute of Cancer Research, Sutton, Surrey, United Kingdom
John M. Carethers, University of Michigan, Ann Arbor, Michigan
Louis Chesler, Institute of Cancer Research, Sutton, United Kingdom
David C. Christiani, Harvard Medical School, Boston, Massachusetts
Mario P. Colombo, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
Joseph N. Contessa, Yale University, New Haven, Connecticut
Lisa M. Coussens, OHSU Knight Cancer Institute, Portland, Oregon
David W. Craig, USC Keck School of Medicine, Los Angeles, California
Christina Curtis, Stanford University, Stanford, California
Riccardo Dalla-Favera, Columbia University Institute for Cancer Genetics, New York, New York
Caroline Dive, Cancer Research UK Manchester Institute, Manchester, United Kingdom
Laura Fejerman, University of California, San Francisco, San Francisco, California
Kevin L. Gardner, Columbia University, New York, New York
David R. Gius, Northwestern University, Chicago, Illinois
Mithat Gönen, Memorial Sloan Kettering Cancer Center, New York, New York
Jennifer Rubin Grandis, University of California, San Francisco, San Francisco, California
John D. Groopman, Johns Hopkins University School of Public Health, Baltimore, Maryland
Susan E. Hankinson, University of Massachusetts Amherst, Amherst, Massachusetts
Jamie N. Holloway, Georgetown University, Washington, District of Columbia
Catriona H.M. Jamieson, UCSD Moores Cancer Center, La Jolla, California
Peter Kuhn, University of Southern California, Los Angeles, California
Sherene Loi, Peter MacCallum Cancer Centre, Camberwell, Victoria, Australia
Thomas J. Lynch, Jr., Bristol-Myers Squibb Co., New York, New York
Crystal L. Mackall, Stanford University School of Medicine, Stanford, California
Tak W. Mak, Campbell Family Institute for Breast Cancer Research, Toronto, Ontario, Canada
Hiroyuki Mano, National Cancer Center Research Institute, Tokyo, Japan
Gordon B. Mills, OHSU Knight Cancer Institute, Portland, Oregon
Lisa A. Newman, Henry Ford Health System, Detroit, Michigan
Kunle Odunsi, Roswell Park Cancer Institute, Buffalo, New York
Moshe Oren, Weizmann Institute of Science, Rehovot, Israel
Klaus Pantel, University Medical Center Hamburg, Hamburg, Germany
William Pao, Roche Pharma Research and Early Development, Basel, Switzerland
Luis F. Parada, Memorial Sloan Kettering Cancer Center, New York, New York
Electra D. Paskett, Ohio State University Comprehensive Cancer Center, Columbus, Ohio
Edith A. Perez, Genentech, Inc., South San Francisco, California
Eric H. Rubin, Merck Research Laboratories, North Wales, Pennsylvania
Anil K. Rustgi, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Patty Spears, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
Victor E. Velculescu, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, Maryland
Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas
E. John Wherry III, University of Pennsylvania, Philadelphia, Pennsylvania
Louis M. Weiner, Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia

About the Location
Atlanta, the capital of and the most populous city in Georgia, is a cultural and economic center of the state and the ninth largest metropolitan area in the United States. The city is the primary transportation hub of the Southeastern United States, via highway, railroad, and air, with Hartsfield–Jackson Atlanta International Airport being the world's busiest airport since 1998. Atlanta is home to nationally renowned private colleges and universities, most notably Emory University, a leading liberal arts and research institution that ranks among the top 20 schools in the United States. Emory University – home to Winship Cancer Institute – also operates Emory Healthcare, the largest health care system in Georgia.

Continuing Medical Education ActivityAMA PRA Category 1 CreditsTM available

Top of page